InvestorsHub Logo
Followers 8
Posts 478
Boards Moderated 0
Alias Born 03/12/2016

Re: Talon38 post# 221798

Tuesday, 12/03/2019 12:07:05 PM

Tuesday, December 03, 2019 12:07:05 PM

Post# of 473341
Talon-it appears to me that these poster presentations and the late breaking oral presentation are all to prove validity of using AI in clinical trials while referencing blarcamesine studies. All of the listed presenters are from Ariana and not by Anavex. AI appears to be the overall theme of this CTAD IMO.
Certainly the emphasis using blarcamesine is great but I don't expect any solid trial information to be presented here. I don't expect to hear anything new until 12/11 at the annual fiscal report presentation. What are your thoughts?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News